Dr Gupta attended the 2025 AAAAI/WAO meeting in San Diego, highlighting new insights into anaphylaxis, angioedema, and urticaria. A key highlight was the consensus statement refining the ...

Dr Ruchi Gupta shares key updates including a new anaphylaxis definition, treatment advances, and emerging biologics for CSU.

an antibody therapy targeting c-Kit to treat mast cell-driven diseases like chronic spontaneous urticaria (CSU) and asthma, at the AAAAI 2025 Annual Meeting in San Diego. The new data, from a ...

Asthma & Immunology annual meeting (AAAAI 2025). LP-003 demonstrated superior improvement compared to Omalizumab in mean change of UAS7 (urticaria activity score 7) from baseline and percentage ...

Inc. (SPRY), a biopharmaceutical company focused on allergic reaction therapies, announced on Tuesday its participation in the 2025 American Academy of Allergy, Asthma, and Immunology or AAAAI ...